Malignant hyperthermia and compartment syndrome.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A M Rutherford.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This is a prospective study of 145 patients whose fetuses presented in the posterior position. Only 31 percent of these delivered spontaneously. Nine were delivered by caesarean section. The remainder were delivered by forceps or ventouse extraction. The management of the posterior presentation is discussed.
Explore the source record for details and available documents.
Fifty women with vaginal Candida albicans infection were given Pimafucin (natamycin) vaginal tablets, two nightly for 10 days. At two weeks there was a 76 percent cure rate which was maintained at four weeks.
Flagyl (metronidazole) was evaluated in the prophylaxis and treatment of patients undergoing gynaecological surgery. One hundred patients were studied: 50 of these patients received prophylactic metronidazole and 50 received matching placebos. Eight percent of metronidazole treated patients developed wound infections which was less than half the number of untreated patients, 18 percent of whom developed wound infection. No anaerobic infections were seen in Flagyl treated patients whereas four (8 percent) were seen in placebo patients.
Cancer of the ovary is the leading cause of death from gynaecological cancer. Forty-six cases are reported to re-emphasise certain features. These include the short history and the high mortality rate regardless of what treatment is used. Whereas improvement has occurred in the treatment of cancer of the corpus and the cervix, there has been no improvement over two decades in cancer of the ovary. The moral of this tale, is to advise your women folk to avoid cancer of the ovary.
A new potent fungicidal preparation, miconazole nitrate 2 percent (Gynodaktarin) was used in 40 patients, both pregnant, with vulvovaginal candidiasis. It was as effective in pregnant as in non-pregnant patients. Retreatment in three cases of recurrence was successful. There were no side effects reported, and the drug was found to be safe for pregnant patients and their offspring.
Explore the source record for details and available documents.
Explore the source record for details and available documents.